Nevirapine clinical trials
Also written Viramune.
Counted the way a researcher would: Nevirapine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Nevirapine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Nevirapine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 21 Jun 1996 · VIRAMUNE · NDA 020636 (FDA, Drugs@FDA)
- European Union
- 4 Feb 1998 · Viramune · EMEA/H/C/000183 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
74 studies that test it; most in 2006 (10)
| Year | Studies |
|---|---|
| 1998 | 3 |
| 1999 | 4 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 5 |
| 2004 | 8 |
| 2005 | 8 |
| 2006 | 10 |
| 2007 | 9 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 33 · Other 65
National Institute of Allergy and Infectious Diseases (NIAID) (28) · Boehringer Ingelheim (26) · Harvard School of Public Health (HSPH) (2) · Germans Trias i Pujol Hospital (2) · International Maternal Pediatric Adolescent AIDS Clinical Trials Group (2) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Bamrasnaradura Infectious Diseases Institute (2) · Bristol-Myers Squibb (2)
Often tested with
Tested in the same studies.
Lamivudine (23) · Zidovudine (21) · Lopinavir-ritonavir drug combination (13) · Stavudine (10) · Ritonavir (9) · Efavirenz (9) · Didanosine (7) · Atazanavir (6)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses Nevirapine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 98
- Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV RemissionRecruitingPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT02140255Written as Nevirapine (NVP)How we know
- Early Infant HIV Treatment in BotswanaActive, not recruitingPhase 2/3Harvard School of Public Health (HSPH)NCT02369406Written as NevirapineHow we know
- An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ SubjectsCompletedPhase 4Boehringer IngelheimNCT00144261Written as nevirapineHow we know
- A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic FunctionsCompletedPhase 4Boehringer IngelheimNCT00144248Written as nevirapineHow we know
- A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral TherapyCompletedPhase 2University of NebraskaNCT01789879Written as NevirapineHow we know
- Using Nevirapine to Prevent Mother-to-Child HIV Transmission During BreastfeedingCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00074412Written as NevirapineHow we know
- Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, BotswanaCompletedPhase 4Ann & Robert H Lurie Children's Hospital of ChicagoNCT03088410Written as NevirapineHow we know
- Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited CountriesCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT01061151Written as Nevirapine (NVP): Antepartum MothersHow we know
- Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in ThailandCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00672412Written as NevirapineHow we know
- Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected ChildrenCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00260078Written as NevirapineHow we know
- Preventing Sexual Transmission of HIV With Anti-HIV DrugsCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00074581Written as NevirapineHow we know
- Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving BirthCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00109590Written as NevirapineHow we know
- Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their NewbornsCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00006396Written as NevirapineHow we know
- A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected MothersCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000808Written as NevirapineHow we know
- A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and DidanosineCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000770Written as NevirapineHow we know
- Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV DrugsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00001083Written as NevirapineHow we know
- Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the DiseaseCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00001045Written as NevirapineHow we know
- Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai ChildrenCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00312091Written as NevirapineHow we know
- Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at BirthCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00102960Written as NevirapineHow we know
- Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIVCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00270296Written as NevirapineHow we know
See all 98 studies that test Nevirapine →
Given beside what is tested · 4 — Nevirapine is usual care or a partner of the new treatment
- Antiretroviral Regime for Viral Eradication in NewbornsCompletedPhase 4National Center for Women and Children's Health, China CDCNCT02712801Written as NevirapineHow we know
- Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-InfectedCompletedPhase 1/2Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsNCT01632891Written as NevirapineHow we know
- Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected PatientsCompletedPhase 4Boehringer IngelheimNCT02184299Written as NevirapineHow we know
- Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African CommunitiesCompletedNot applicableCIPRA SANCT00255840Written as NevirapineHow we know
As the comparator · 5 — what is tested is compared with Nevirapine
- Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV PatientsTerminatedPhase 4Germans Trias i Pujol HospitalNCT00661349Written as NevirapineHow we know
- Pharmacoscintigraphic Investigation Into the Absorption of Nevirapine When Released Into Different Parts of the Gastro-intestinal Tract in Healthy MalesCompletedPhase 1Boehringer IngelheimNCT02191189Written as Nevirapine suspensionHow we know
- Pharmacokinetic Properties of Two Dosages Nevirapine Extended Release (XR) Formulations Compared to VIRAMUNE® Tablet as Well as to Nevirapine XR Tablet in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02184312Written as Nevirapine (VIRAMUNE®)How we know
- Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited SettingCompletedPhase 4Centre Hospitalier Universitaire Saint PierreNCT01772940Written as nevirapineHow we know
- Triomune Bioequivalence With InnovatorsCompletedPhase 4Makerere UniversityNCT01025830Written as Zerit/Epivir/ViramuneHow we know
Codes
What other systems call Nevirapine · ClinicalTrials.gg INT008731
- MeSH (NLM) D019829NevirapineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 99DK7FVK1HNEVIRAPINEConfirmed FDA, NLM, Wikidata
- RxNorm 53654Confirmed FDA, Wikidata
- Wikidata Q263713nevirapineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29277NevirapineOne source FDA
- DrugBank DB00238One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019829 | Nevirapine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 99DK7FVK1H | NEVIRAPINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 53654 | — | Confirmed FDA, Wikidata |
| Wikidata | Q263713 | nevirapine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29277 | Nevirapine | One source FDA |
| DrugBank | DB00238 | — | One source Wikidata |
Also registered as nevirapine hemihydrate (UNII B7XF2TD73C · RxNorm 2462459).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.